Trial Profile
Angiotensin Converting Enzyme Inhibitor (ACE) Induced Angioedema BERINERT Randomized, double-blind, two arms, multicenter, Phase III study of Berinert for treatment of ACE induced Angioedema
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 15 Oct 2018
Price :
$35
*
At a glance
- Drugs Complement C1 inhibitor protein (Primary) ; Prednisolone
- Indications Angioedema
- Focus Therapeutic Use
- Acronyms BERINERT
- 15 Oct 2018 New trial record